Christ Hospital in Cincinnati Receives FDA Approval to Treat Sickest COVID-19 Patients with 'Convalescent Plasma'


  • ANJSIMMO // CC BY 2.0
On Thursday, it was announced that The Christ Hospital Lindner Research Center received approval from the U.S. Food and Drug Administration to start treating high-risk and very ill COVID-19 patients with convalescent plasma, or the plasma from patients who have recovered from the coronavirus.

"Hospitals in Cincinnati, Columbus and Cleveland have all expressed interest in participating in the treatment protocol," said Lt. Governor Jon Husted in the state's daily coronavirus briefing. "This is another great step in our efforts to save lives."

According to the Ohio Department of Health, "Convalescent plasma is rich in antibodies that could possibly attack the virus that causes COVID-19. It shows promise to lessen the severity or shorten the length of COVID-19."

While currently just an investigative treatment, the thought is that an infusion of blood from a recovered patient will give sick patients the COVID-19 antibodies to help them fight off the virus. Plasma is only obtained from patients who have been recovered from the virus for at least two weeks and it is thought each plasma donation could potentially help up to four patients.

The FDA is just approving the infusions through "an emergency investigational new drug application process with academic institutions to evaluate its safety and efficacy," says the Ohio Department of Health. The FDA says the hope is that thousands of units of plasma will be available to patients in the coming weeks.

If you want to know about the plasma program or what patients qualify for receiving plasma, visit The basic requirements are, according to the Mayo Clinic, which is spearheading the plasma program:

Patients are 18+ years of age

They have a laboratory-confirmed diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19

They are admitted to an acute care facility for the treatment of COVID-19 complications

They have severe or life-threatening COVID-19, or judged by the treating provider to be at high risk of progression to severe or life-threatening disease

There is informed consent provided by the patient or healthcare proxy

They also have to be treated at a participating center — like the Christ Hospital Lindner Research Center

Health care providers not directly associated with a study can submit applications through certain pathways for individual patients.

If you are a patient who has recovered from COVID-19 and want to learn more about donating your plasma, visit

We welcome readers to submit letters regarding articles and content in Cleveland Scene. Letters should be a minimum of 150 words, refer to content that has appeared on Cleveland Scene, and must include the writer's full name, address, and phone number for verification purposes. No attachments will be considered. Writers of letters selected for publication will be notified via email. Letters may be edited and shortened for space.

Email us at

Support Local Journalism.
Join the Cleveland Scene Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the Cleveland Scene Press Club for as little as $5 a month.